| [1] |
Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol, 2012, 25(9): 1181-1192.
|
| [2] |
Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by auto immune abnormality. Proposal of concept autoimmune pancreatitis[J]. Dig Dis Sci, 1995, 40(7): 1561-1568.
|
| [3] |
Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis[J]. N Engl J Med, 2001, 345(2): 732-738.
|
| [4] |
Hamanou H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis[J]. Lancet, 2002, 359(9315): 1403-1404.
|
| [5] |
Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease[J]. J Gastroenterol, 2003, 38(10): 982-984.
|
| [6] |
Kamisawa T, Okamoto A, Kamisawa T, et al. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease[J]. J Gastroenterol, 2006, 41(7): 613-625.
|
| [7] |
Takahashi H, Yamamoto M, Suzuki C, et al. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity[J]. Autoimmun Rev, 2010, 9(9): 591-594.
|
| [8] |
曹雅楠, 韦欣, 丁慧, 等. IgG4相关性疾病患者异常实验室结果的分析[J]. 中华检验医学杂志, 2017, 40(2):143-145. CAO Yanan, WEI Xin, DING Hui, et al. Interpretation of abnormal laboratory test results in patients with IgG4 related disease[J]. Chin J Lab Med, 2017, 40(2): 143-145.
|
| [9] |
Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease[J]. Clin Exp Immunol, 2015, 181(2): 191-206.
|
| [10] |
Takeuchi M, Sato Y, Ohno K, et al.T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease[J]. Mod Pathol, 2014, 27(8): 1126-1136.
|
| [11] |
Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients[J]. Arthritis Rheumatol, 2015, 67(9): 2466-2475.
|
| [12] |
Fragoulis GE, Moutsopoulos HM. IgG4 syndrome: old disease, new perspective[J]. J Rheumatol, 2010, 37(7): 1369-1370.
|
| [13] |
Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders[J]. Ann Rheum Dis, 2009, 68(8): 1310-1315.
|
| [14] |
Kamisawa T, Chen PY, Tu Y, et al. Pancreatic cancer with a high serum IgG4 concentration[J]. World J Gastroenterol, 2006, 12(38): 6225-6228.
|
| [15] |
Moriyama M, Ohta M, Furukawa S, et al. The diagnostic utility of labial salivary gland biopsy in IgG4-related disease[J]. Mod Rheumatol, 2016, 26(5): 725-729.
|
| [16] |
Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD), 2011[J]. Mod Rheumatol, 2012, 22(1): 21-30.
|
| [17] |
Umeda M, Fujikawa K, Origuchi T, et al. A case of IgG4-related pulmonary disease with rapid improvement[J]. Mod Rheumatol, 2012, 22(6): 919-923.
|
| [18] |
Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations[J]. Radiology, 2009, 251(1): 260-270.
|
| [19] |
张宇, 黄少祥, 许建春,等. 肺部受累的IgG4相关性疾病1例并文献复习[J]. 重庆医学, 2016, 45(32):4604-4606.
|
| [20] |
张伟, 薛峰, 刘孟春, 等. 36例IgG4相关性疾病的临床分析[J]. 中华肾脏病杂志, 2016, 32(4): 253-258. ZHANG Wei, XUE Feng, LIU Mengchun, et al. Clinical analysis of 36 cases of IgG4-related disease[J]. Chin J Neahrol, 2016, 32(4): 253-258.
|
| [21] |
Shimizu Y, Yamamoto M, Naishiro Y, et al. Necessity of early intervention for IgG4-related disease-delayed treatment induces fibrosis progression[J]. Rheumatology(Oxford), 2013, 52(4): 679-683.
|
| [22] |
Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-Related disease[J]. Arthritis Rheumatol, 2015, 67(7): 1688-1699.
|
| [23] |
Carruthers MN, Topazian MD, Khosroshahi A, et al. Rituximab for IgG4-related disease: a prospective, open-label trial[J]. Ann Rheum Dis, 2015, 74(6): 1171-1177.
|
